143 related articles for article (PubMed ID: 37865858)
21. Neoadjuvant Stereotactic Radiosurgery: a Further Evolution in the Management of Brain Metastases.
Udovicich C; Phillips C; Kok DL; Tange D; Plumridge NM; Prabhu RS; Haghighi N
Curr Oncol Rep; 2019 Jul; 21(8):73. PubMed ID: 31270629
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery.
Tang JD; Mills MN; Nakashima J; Dohm AE; Khushalani NI; Forsyth PA; Vogelbaum MA; Wuthrick EJ; Yu HM; Oliver DE; Liu JKC; Ahmed KA
J Neurooncol; 2024 Feb; 166(3):431-440. PubMed ID: 38310157
[TBL] [Abstract][Full Text] [Related]
23. Concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for metastatic brain disease: a systematic review and meta-analysis.
Lu VM; Goyal A; Rovin RA; Lee A; McDonald KL
J Neurooncol; 2019 Jan; 141(1):1-12. PubMed ID: 30392086
[TBL] [Abstract][Full Text] [Related]
24. Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: An international meta-analysis of individual patient data.
Lehrer EJ; Peterson J; Brown PD; Sheehan JP; Quiñones-Hinojosa A; Zaorsky NG; Trifiletti DM
Radiother Oncol; 2019 Jan; 130():104-112. PubMed ID: 30241791
[TBL] [Abstract][Full Text] [Related]
25. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
[TBL] [Abstract][Full Text] [Related]
26. Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: An international multicenter study.
Lehrer EJ; Gurewitz J; Bernstein K; Patel D; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Malouff TD; Ruiz-Garcia H; Patel S; Bonney PA; Hwang L; Yu C; Zada G; Mathieu D; Trudel C; Prasad RN; Palmer JD; Jones BM; Sharma S; Fakhoury KR; Rusthoven CG; Deibert CP; Picozzi P; Franzini A; Attuati L; Lee CC; Yang HC; Ahluwalia MS; Sheehan JP; Trifiletti DM
Cancer; 2022 Apr; 128(7):1429-1438. PubMed ID: 35077586
[TBL] [Abstract][Full Text] [Related]
27. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar A; Kondziolka D; Lunsford LD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1125-32. PubMed ID: 15990018
[TBL] [Abstract][Full Text] [Related]
28. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis.
Donovan EK; Parpia S; Greenspoon JN
Curr Oncol; 2019 Jun; 26(3):e328-e333. PubMed ID: 31285676
[TBL] [Abstract][Full Text] [Related]
29. Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patients.
Lehrer EJ; Ahluwalia MS; Gurewitz J; Bernstein K; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Fakhoury KR; Rusthoven CG; Mathieu D; Trudel C; Malouff TD; Ruiz-Garcia H; Bonney P; Hwang L; Yu C; Zada G; Patel S; Deibert CP; Picozzi P; Franzini A; Attuati L; Prasad RN; Raval RR; Palmer JD; Lee CC; Yang HC; Jones BM; Green S; Sheehan JP; Trifiletti DM
J Neurosurg; 2023 May; 138(5):1178-1187. PubMed ID: 36115055
[TBL] [Abstract][Full Text] [Related]
30. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E; Eaton BR; Olson JJ; Curran WJ; Shu HG; Crocker IR; Patel KR
J Neurosurg; 2018 Apr; 130(3):797-803. PubMed ID: 29676690
[TBL] [Abstract][Full Text] [Related]
31. The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.
Martins F; Schiappacasse L; Levivier M; Tuleasca C; Cuendet MA; Aedo-Lopez V; Gautron Moura B; Homicsko K; Bettini A; Berthod G; Gérard CL; Wicky A; Bourhis J; Michielin O
J Neurooncol; 2020 Jan; 146(1):181-193. PubMed ID: 31836957
[TBL] [Abstract][Full Text] [Related]
32. Single versus Multifraction Stereotactic Radiosurgery for Large Brain Metastases: An International Meta-analysis of 24 Trials.
Lehrer EJ; Peterson JL; Zaorsky NG; Brown PD; Sahgal A; Chiang VL; Chao ST; Sheehan JP; Trifiletti DM
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):618-630. PubMed ID: 30395902
[TBL] [Abstract][Full Text] [Related]
33. The impact of sequencing PD-1/PD-L1 inhibitors and stereotactic radiosurgery for patients with brain metastasis.
Kotecha R; Kim JM; Miller JA; Juloori A; Chao ST; Murphy ES; Peereboom DM; Mohammadi AM; Barnett GH; Vogelbaum MA; Angelov L; Suh JH; Ahluwalia MS
Neuro Oncol; 2019 Aug; 21(8):1060-1068. PubMed ID: 30796838
[TBL] [Abstract][Full Text] [Related]
34. Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients.
Lehrer EJ; Khosla AA; Ozair A; Gurewitz J; Bernstein K; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Mathieu D; Trudel C; Deibert CP; Malouff TD; Ruiz-Garcia H; Peterson JL; Patel S; Bonney P; Hwang L; Yu C; Zada G; Picozzi P; Franzini A; Attuati L; Prasad RN; Raval RR; Palmer JD; Lee CC; Yang HC; Fakhoury KR; Rusthoven CG; Dickstein DR; Sheehan JP; Trifiletti DM; Ahluwalia MS
J Neurooncol; 2023 Oct; 165(1):63-77. PubMed ID: 37889444
[TBL] [Abstract][Full Text] [Related]
35. Integration of immuno-oncology with stereotactic radiosurgery in the management of brain metastases.
Lehrer EJ; McGee HM; Sheehan JP; Trifiletti DM
J Neurooncol; 2021 Jan; 151(1):75-84. PubMed ID: 32052355
[TBL] [Abstract][Full Text] [Related]
36. Treatment of high numbers of brain metastases with Gamma Knife radiosurgery: a review.
Hatiboglu MA; Tuzgen S; Akdur K; Chang EL
Acta Neurochir (Wien); 2016 Apr; 158(4):625-634. PubMed ID: 26811300
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases.
Lehrer EJ; McGee HM; Peterson JL; Vallow L; Ruiz-Garcia H; Zaorsky NG; Sharma S; Trifiletti DM
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301252
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic Radiosurgery for Postoperative Metastatic Surgical Cavities: A Critical Review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines.
Redmond KJ; De Salles AAF; Fariselli L; Levivier M; Ma L; Paddick I; Pollock BE; Regis J; Sheehan J; Suh J; Yomo S; Sahgal A
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):68-80. PubMed ID: 33891979
[TBL] [Abstract][Full Text] [Related]
39. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
40. Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment.
Anderson ES; Postow MA; Wolchok JD; Young RJ; Ballangrud Å; Chan TA; Yamada Y; Beal K
J Immunother Cancer; 2017 Oct; 5(1):76. PubMed ID: 29037215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
